Vertex Pharmaceuticals Inc / Ma

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

3,978

Value ($000)

1,886

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	1,886	0.0%	3,978	12/31/2025
2025 Q3	10/24/2025	1,669	0.0%	3,950	9/30/2025
2025 Q2	7/30/2025	331	0.0%	744	6/30/2025
2025 Q1	4/24/2025	342	0.0%	694	3/31/2025
2024 Q4	1/28/2025	308	0.0%	694	12/31/2024
2024 Q3	10/25/2024	311	0.0%	660	9/30/2024
2024 Q2	7/17/2024	273	0.0%	559	6/30/2024
2024 Q1	4/23/2024	224	0.0%	559	3/31/2024
2023 Q4	2/1/2024	237	0.0%	547	12/31/2023
2023 Q3	11/3/2023	206	0.0%	547	9/30/2023
2023 Q2	8/1/2023	192	0.0%	547	6/30/2023
2023 Q1	5/2/2023	170	0.0%	540	3/31/2023
2022 Q4	3/2/2023	114	0.0%	395	12/31/2022
2022 Q3	10/25/2022	114	0.0%	395	9/30/2022
2022 Q2	7/26/2022	111	0.0%	395	6/30/2022
2022 Q1	4/13/2022	80	0.0%	305	3/31/2022
2021 Q4	2/14/2022	67	0.0%	305	12/31/2021
2021 Q3	11/12/2021	57	0.0%	315	9/30/2021
2021 Q2	8/13/2021	69	0.0%	340	6/30/2021
2020 Q4	1/14/2021	180	0.0%	761	12/31/2020
2020 Q3	10/15/2020	254	0.0%	935	9/30/2020
2020 Q2	7/30/2020	271	0.0%	935	6/30/2020
2020 Q1	4/15/2020	163	0.0%	685	3/31/2020
2019 Q4	1/22/2020	185	0.0%	844	12/31/2019
2014 Q1	4/28/2014	92	0.0%	1,300	3/31/2014
2013 Q4	2/11/2014	110	0.0%	1,477	12/31/2013